Hyaluronic  ||| S:0 E:11 ||| FW
acid  ||| S:11 E:16 ||| FW
injection  ||| S:16 E:26 ||| FW
Hyaluronic  ||| S:26 E:37 ||| FW
acid  ||| S:37 E:42 ||| FW
is  ||| S:42 E:45 ||| VBZ
currently  ||| S:45 E:55 ||| RB
the  ||| S:55 E:59 ||| DT
leading  ||| S:59 E:67 ||| JJ
product  ||| S:67 E:75 ||| NN
for  ||| S:75 E:79 ||| IN
the  ||| S:79 E:83 ||| DT
treatment  ||| S:83 E:93 ||| NN
of  ||| S:93 E:96 ||| IN
wrinkles ||| S:96 E:104 ||| NN
.  ||| S:104 E:106 ||| .
The  ||| S:106 E:110 ||| DT
side  ||| S:110 E:115 ||| NN
effects  ||| S:115 E:123 ||| NNS
are  ||| S:123 E:127 ||| VBP
few  ||| S:127 E:131 ||| JJ
compared  ||| S:131 E:140 ||| VBN
to  ||| S:140 E:143 ||| TO
the  ||| S:143 E:147 ||| DT
number  ||| S:147 E:154 ||| NN
of  ||| S:154 E:157 ||| IN
patients  ||| S:157 E:166 ||| NNS
treated ||| S:166 E:173 ||| VBN
.  ||| S:173 E:175 ||| .
Hyaluronic  ||| S:175 E:186 ||| JJ
acid  ||| S:186 E:191 ||| NN
gives  ||| S:191 E:197 ||| VBZ
security  ||| S:197 E:206 ||| NN
and  ||| S:206 E:210 ||| CC
efficiency  ||| S:210 E:221 ||| NN
to  ||| S:221 E:224 ||| TO
the  ||| S:224 E:228 ||| DT
patient ||| S:228 E:235 ||| NN
,  ||| S:235 E:237 ||| ,
which  ||| S:237 E:243 ||| WDT
is  ||| S:243 E:246 ||| VBZ
important  ||| S:246 E:256 ||| JJ
foe  ||| S:256 E:260 ||| JJ
cosmetic  ||| S:260 E:269 ||| JJ
indication ||| S:269 E:279 ||| NN
.  ||| S:279 E:281 ||| .
